Jul. 15 at 7:42 PM
$HAWK For those who have been tracking this story with me... or if you're just getting introduced to it today... I wanted to lay out exactly why this is such a compelling asymmetric opportunity on my radar rn and how I'm actively trading it.
To be sure, we're looking at a classic institutional disconnect with HawkEye 360. After the co officially priced its May IPO at
$26, a standard post-IPO liquidity flush dragged the stock down to sub-
$20 levels. This pullback, IMO, is an absolute gift for patient capital, especially when you look at the heavy-hitting analyst targets coming from the Street's top trading desks.
$GS: Goldman Sachs is setting a
$42.00 price target.
$MS: Morgan Stanley recently initiated coverage on the company with an Overweight rating and a
$41.00 price target, highlighting that their unique data analytics overlay creates highly-differentiated demand.
Baird: Baird is backing the thesis with a
$41.00 price target.
$RY: RBC Capital Markets is on board with an Outperform rating and a
$40.00 price target.
William Blair: William Blair has also initiated with an Outperform rating.
$JEF: Jefferies is aggressively upgrading the stock to a Buy on this exact dip with a
$34.00 price target (upgraded from their initial June 1 Hold rating).
BAC: BofA Securities is Neutral with a
$34.00 price target.
When top desks concentrate their targets more than 100% above current levels, the market's pricing inefficiency sub-
$20 becomes glaring. The fundamental engine here is backed by an incredibly deep competitive moat and premier proprietary technology. HawkEye 360 operates a first-of-its-kind constellation of over 30 satellites that map and geolocate radio frequency (RF) emissions globally from space. This unique capability is critical for modern electronic warfare, securing them core contracts with the National Reconnaissance Office (NRO), the U.S. Navy, and key allied foreign governments. The demand for this high-moat intelligence is scaling rapidly, with the company having already "Announced over
$100 million in new international contract awards in 2026" while they "Confirmed backlog of
$285.0 million at quarter end."
Financially, this is a rapid-scale story rather than a speculative bet. In their latest quarter, the company "Achieved record revenue of
$49.8 million, up 116.5% compared to the prior-year period of
$23.0 million" while they "Realized record adjusted EBITDA, a non-GAAP metric, of
$7.4 million, up 92.1% compared to the prior-year period of
$3.8 million."
My tactical execution here is simple. I hold a core common equity position from the IPO which I've aggressively accumulated under the
$20.00 level. To maximize yield on this consolidation, I'm also writing short puts, taking advantage of the inflated IV to collect a fat premium. To conclude, this is a rare convergence of triple-digit growth, a massive federal backlog, and high-conviction institutional backing trading at a massive discount... and I'm happy to participate. As always, I'm just sharing my thoughts. Please do your own DD. NFA.
